vs
Side-by-side financial comparison of GLOBAL INDUSTRIAL Co (GIC) and P3 Health Partners Inc. (PIII). Click either name above to swap in a different company.
P3 Health Partners Inc. is the larger business by last-quarter revenue ($384.8M vs $345.6M, roughly 1.1× GLOBAL INDUSTRIAL Co). GLOBAL INDUSTRIAL Co runs the higher net margin — 4.2% vs -19.6%, a 23.8% gap on every dollar of revenue. On growth, GLOBAL INDUSTRIAL Co posted the faster year-over-year revenue change (14.3% vs 3.8%). Over the past eight quarters, GLOBAL INDUSTRIAL Co's revenue compounded faster (3.4% CAGR vs -0.5%).
Global Industrial Company is a Port Washington, New York–based company providing industrial and MRO products through a system of branded e-Commerce websites and relationship marketers in North America. The primary brand is Global Industrial.
P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.
GIC vs PIII — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $345.6M | $384.8M |
| Net Profit | $14.6M | $-75.5M |
| Gross Margin | 34.5% | — |
| Operating Margin | 5.7% | -40.0% |
| Net Margin | 4.2% | -19.6% |
| Revenue YoY | 14.3% | 3.8% |
| Net Profit YoY | 36.4% | -28.8% |
| EPS (diluted) | $0.37 | $-23.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $345.6M | $384.8M | ||
| Q3 25 | $353.6M | $345.3M | ||
| Q2 25 | $358.9M | $355.8M | ||
| Q1 25 | $321.0M | $373.2M | ||
| Q4 24 | $302.3M | $370.7M | ||
| Q3 24 | $342.4M | $362.1M | ||
| Q2 24 | $347.8M | $379.2M | ||
| Q1 24 | $323.4M | $388.5M |
| Q4 25 | $14.6M | $-75.5M | ||
| Q3 25 | $18.8M | $-31.6M | ||
| Q2 25 | $25.1M | $-20.4M | ||
| Q1 25 | $13.6M | $-20.5M | ||
| Q4 24 | $10.7M | $-58.6M | ||
| Q3 24 | $16.8M | $-46.5M | ||
| Q2 24 | $20.3M | $-12.0M | ||
| Q1 24 | $13.2M | $-18.7M |
| Q4 25 | 34.5% | — | ||
| Q3 25 | 35.6% | — | ||
| Q2 25 | 37.1% | — | ||
| Q1 25 | 34.9% | — | ||
| Q4 24 | 33.8% | — | ||
| Q3 24 | 34.0% | — | ||
| Q2 24 | 35.2% | — | ||
| Q1 24 | 34.3% | — |
| Q4 25 | 5.7% | -40.0% | ||
| Q3 25 | 7.4% | -12.8% | ||
| Q2 25 | 9.3% | -9.6% | ||
| Q1 25 | 5.7% | -10.2% | ||
| Q4 24 | 4.8% | -37.4% | ||
| Q3 24 | 6.5% | -29.5% | ||
| Q2 24 | 7.6% | -8.3% | ||
| Q1 24 | 5.4% | -11.3% |
| Q4 25 | 4.2% | -19.6% | ||
| Q3 25 | 5.3% | -9.1% | ||
| Q2 25 | 7.0% | -5.7% | ||
| Q1 25 | 4.2% | -5.5% | ||
| Q4 24 | 3.5% | -15.8% | ||
| Q3 24 | 4.9% | -12.8% | ||
| Q2 24 | 5.8% | -3.2% | ||
| Q1 24 | 4.1% | -4.8% |
| Q4 25 | $0.37 | $-23.08 | ||
| Q3 25 | $0.48 | $-9.67 | ||
| Q2 25 | $0.65 | $-6.23 | ||
| Q1 25 | $0.35 | $-6.28 | ||
| Q4 24 | $0.28 | $-23.13 | ||
| Q3 24 | $0.44 | $-15.70 | ||
| Q2 24 | $0.52 | $-7.37 | ||
| Q1 24 | $0.34 | $-7.86 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $67.5M | $25.0M |
| Total DebtLower is stronger | — | $228.4M |
| Stockholders' EquityBook value | $313.2M | $-155.2M |
| Total Assets | $580.8M | $656.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $67.5M | $25.0M | ||
| Q3 25 | $67.2M | $37.7M | ||
| Q2 25 | $55.1M | $38.6M | ||
| Q1 25 | $39.0M | $40.1M | ||
| Q4 24 | $44.6M | $38.8M | ||
| Q3 24 | $38.9M | $63.0M | ||
| Q2 24 | $38.8M | $73.1M | ||
| Q1 24 | $29.9M | $27.3M |
| Q4 25 | — | $228.4M | ||
| Q3 25 | — | $252.8M | ||
| Q2 25 | — | $182.0M | ||
| Q1 25 | — | $171.1M | ||
| Q4 24 | — | $108.9M | ||
| Q3 24 | — | $133.2M | ||
| Q2 24 | — | $133.1M | ||
| Q1 24 | — | $118.1M |
| Q4 25 | $313.2M | $-155.2M | ||
| Q3 25 | $316.0M | $-18.7M | ||
| Q2 25 | $305.2M | $44.5M | ||
| Q1 25 | $287.9M | $63.3M | ||
| Q4 24 | $281.1M | $75.9M | ||
| Q3 24 | $279.2M | $120.5M | ||
| Q2 24 | $270.4M | $166.8M | ||
| Q1 24 | $260.2M | $146.6M |
| Q4 25 | $580.8M | $656.6M | ||
| Q3 25 | $602.5M | $683.6M | ||
| Q2 25 | $586.5M | $731.6M | ||
| Q1 25 | $536.7M | $783.9M | ||
| Q4 24 | $520.7M | $783.4M | ||
| Q3 24 | $531.6M | $833.3M | ||
| Q2 24 | $542.5M | $892.8M | ||
| Q1 24 | $517.4M | $855.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 4.09× | ||
| Q1 25 | — | 2.71× | ||
| Q4 24 | — | 1.43× | ||
| Q3 24 | — | 1.11× | ||
| Q2 24 | — | 0.80× | ||
| Q1 24 | — | 0.81× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.0M | $-25.7M |
| Free Cash FlowOCF − Capex | $19.2M | — |
| FCF MarginFCF / Revenue | 5.6% | — |
| Capex IntensityCapex / Revenue | 0.2% | — |
| Cash ConversionOCF / Net Profit | 1.37× | — |
| TTM Free Cash FlowTrailing 4 quarters | $74.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.0M | $-25.7M | ||
| Q3 25 | $22.7M | $-15.4M | ||
| Q2 25 | $31.7M | $-16.6M | ||
| Q1 25 | $3.4M | $-33.5M | ||
| Q4 24 | $15.9M | $-57.2M | ||
| Q3 24 | $9.6M | $-22.6M | ||
| Q2 24 | $18.8M | $-10.2M | ||
| Q1 24 | $6.4M | $-20.0M |
| Q4 25 | $19.2M | — | ||
| Q3 25 | $22.0M | — | ||
| Q2 25 | $30.3M | — | ||
| Q1 25 | $3.2M | — | ||
| Q4 24 | $15.2M | — | ||
| Q3 24 | $8.7M | — | ||
| Q2 24 | $17.9M | — | ||
| Q1 24 | $5.1M | — |
| Q4 25 | 5.6% | — | ||
| Q3 25 | 6.2% | — | ||
| Q2 25 | 8.4% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 5.0% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 1.6% | — |
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.2% | 0.0% | ||
| Q3 24 | 0.3% | 0.0% | ||
| Q2 24 | 0.3% | 0.0% | ||
| Q1 24 | 0.4% | 0.0% |
| Q4 25 | 1.37× | — | ||
| Q3 25 | 1.21× | — | ||
| Q2 25 | 1.26× | — | ||
| Q1 25 | 0.25× | — | ||
| Q4 24 | 1.49× | — | ||
| Q3 24 | 0.57× | — | ||
| Q2 24 | 0.93× | — | ||
| Q1 24 | 0.48× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GIC
Segment breakdown not available.
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
